Rhenium Nanoliposomes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rhenium Nanoliposomes, covering 2025-03-26 to 2025-03-26. Get the full timeline:
Most recent: Clinical Trial Update: Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) [Phase 1, Phase 2]